These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11098560)

  • 21. Amiodarone: what have we learned from clinical trials?
    Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
    Clin Cardiol; 2000 Feb; 23(2):73-82. PubMed ID: 10676597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 25. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of arrhythmias in heart failure.
    Stevenson WG; Ellison KE; Sweeney MO; Epstein LM; Maisel WH
    Cardiol Rev; 2002; 10(1):8-14. PubMed ID: 11790264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
    Dardas TF; Aaronson KD
    Circulation; 2010 Oct; 122(15):e486; author reply e487. PubMed ID: 20937985
    [No Abstract]   [Full Text] [Related]  

  • 31. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
    Mosller M
    Clin Cardiol; 1997 Aug; 20(8):704-10. PubMed ID: 9259163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 33. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W; Maisch B
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators.
    Bunch TJ; Anderson JL
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):89-100. PubMed ID: 24288157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone in congestive heart failure.
    Singh S
    Int J Clin Pract; 1998 Sep; 52(6):432-5. PubMed ID: 9894384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Blatt JA; Poole JE; Johnson GW; Callans DJ; Raitt MH; Reddy RK; Marchlinski FE; Yee R; Guarnieri T; Talajic M; Wilber DJ; Anderson J; Chung K; Wong WS; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Aug; 52(7):551-6. PubMed ID: 18687249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death.
    Kamath GS; Mittal S
    Prog Cardiovasc Dis; 2008; 50(6):439-48. PubMed ID: 18474286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.